1. Home
  2. UHG vs NKTX Comparison

UHG vs NKTX Comparison

Compare UHG & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UHG
  • NKTX
  • Stock Information
  • Founded
  • UHG 2004
  • NKTX 2015
  • Country
  • UHG United States
  • NKTX United States
  • Employees
  • UHG N/A
  • NKTX N/A
  • Industry
  • UHG Homebuilding
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UHG Consumer Discretionary
  • NKTX Health Care
  • Exchange
  • UHG Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • UHG 281.1M
  • NKTX 225.1M
  • IPO Year
  • UHG N/A
  • NKTX 2020
  • Fundamental
  • Price
  • UHG $6.12
  • NKTX $3.23
  • Analyst Decision
  • UHG
  • NKTX Strong Buy
  • Analyst Count
  • UHG 0
  • NKTX 5
  • Target Price
  • UHG N/A
  • NKTX $18.20
  • AVG Volume (30 Days)
  • UHG 20.9K
  • NKTX 760.2K
  • Earning Date
  • UHG 11-08-2024
  • NKTX 11-11-2024
  • Dividend Yield
  • UHG N/A
  • NKTX N/A
  • EPS Growth
  • UHG 47.07
  • NKTX N/A
  • EPS
  • UHG 2.33
  • NKTX N/A
  • Revenue
  • UHG $414,814,052.00
  • NKTX N/A
  • Revenue This Year
  • UHG N/A
  • NKTX N/A
  • Revenue Next Year
  • UHG N/A
  • NKTX N/A
  • P/E Ratio
  • UHG $2.58
  • NKTX N/A
  • Revenue Growth
  • UHG N/A
  • NKTX N/A
  • 52 Week Low
  • UHG $5.09
  • NKTX $1.90
  • 52 Week High
  • UHG $9.48
  • NKTX $16.24
  • Technical
  • Relative Strength Index (RSI)
  • UHG 58.85
  • NKTX 33.30
  • Support Level
  • UHG $5.39
  • NKTX $3.08
  • Resistance Level
  • UHG $6.23
  • NKTX $3.52
  • Average True Range (ATR)
  • UHG 0.37
  • NKTX 0.27
  • MACD
  • UHG 0.05
  • NKTX 0.01
  • Stochastic Oscillator
  • UHG 77.88
  • NKTX 15.23

About UHG United Homes Group Inc

United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: